Literature DB >> 21699019

Role of reactive oxygen species (ROS) in CDDO-Me-mediated growth inhibition and apoptosis in colorectal cancer cells.

Xiaohua Gao1, Dorrah Deeb, Patricia Liu, Yongbo Liu, Syed Arbab-Ali, Scott A Dulchavsky, Subhash C Gautam.   

Abstract

CDDO-Me, an oleanane synthetic triterpenoid has shown strong antitumorigeic activity towards diverse cancer cell types including colorectal cancer cells. In the present study, we investigated the role of free radicals in the growth inhibitory and apoptosis-inducing activity of CDDO-Me in colorectal cancer cells lines. Results demonstrated that CDDO-Me potently inhibited the growth of colorectal cancer cells and pretreatment of cancer cells with small-molecule antioxidant N-acetylcysteine (NAC) completely blocked the growth inhibitory activity of CDDO-Me. CDDO-Me caused the generation of reactive oxygen species, which was inhibited by NAC and mitochondrial chain 1 complex inhibitors DPI and rotenone. CDDO-Me induced apoptosis as demonstrated by the cleavage of PARP-1, activation of procaspases -3, -8, and -9 and mitochondrial depolarization and NAC blocked the activation of these apoptosis related processes. Furthermore, induction of apoptosis by CDDO-Me was associated with the inhibition of antiapoptotic/ prosurvival Akt, mTOR and NF-kappaB signaling proteins and the inhibition of these signaling molecules was blocked by NAG. Together these studies provided evidence that CDDO-Me is a potent anticancer agent, which imparts growth inhibition and apoptosis in colorectal cancer cells through the generation of free radicals.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21699019      PMCID: PMC3750951     

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN: 1359-4117


  32 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

2.  Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia.

Authors:  Marina Konopleva; Twee Tsao; Peter Ruvolo; Irina Stiouf; Zeev Estrov; Clinton E Leysath; Shourong Zhao; David Harris; Shirong Chang; C Ellen Jackson; Mark Munsell; Nanjoo Suh; Gordon Gribble; Tadashi Honda; W Stratford May; Michael B Sporn; Michael Andreeff
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

3.  4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NF-kappaB signaling pathways.

Authors:  Seung J Lee; Kyo W Seo; Mi R Yun; Sun S Bae; Won S Lee; Ki W Hong; Chi D Kim
Journal:  Free Radic Biol Med       Date:  2008-09-06       Impact factor: 7.376

4.  The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism.

Authors:  Y Ito; P Pandey; M B Sporn; R Datta; S Kharbanda; D Kufe
Journal:  Mol Pharmacol       Date:  2001-05       Impact factor: 4.436

5.  Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-{kappa}B signaling proteins in colorectal cancer cells.

Authors:  Xiaohua Gao; Dorrah Deeb; Jiang Hao; Yongbo Liu; Ali S Arbab; Scott A Dulchavsky; Subhash C Gautam
Journal:  Anticancer Res       Date:  2010-03       Impact factor: 2.480

Review 6.  The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.

Authors:  M Hidalgo; E K Rowinsky
Journal:  Oncogene       Date:  2000-12-27       Impact factor: 9.867

Review 7.  The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance.

Authors:  M W Mayo; A S Baldwin
Journal:  Biochim Biophys Acta       Date:  2000-03-27

8.  Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.

Authors:  C V Rao; Y Hirose; C Indranie; B S Reddy
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

9.  Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.

Authors:  Nanjoo Suh; Anita B Roberts; Stephanie Birkey Reffey; Kohei Miyazono; Susumu Itoh; Peter ten Dijke; Elke H Heiss; Andrew E Place; Renee Risingsong; Charlotte R Williams; Tadashi Honda; Gordon W Gribble; Michael B Sporn
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

Review 10.  Cellular response to oxidative stress: signaling for suicide and survival.

Authors:  Jennifer L Martindale; Nikki J Holbrook
Journal:  J Cell Physiol       Date:  2002-07       Impact factor: 6.384

View more
  7 in total

1.  Radiation protection of the gastrointestinal tract and growth inhibition of prostate cancer xenografts by a single compound.

Authors:  Vitali Alexeev; Elizabeth Lash; April Aguillard; Laura Corsini; Avi Bitterman; Keith Ward; Adam P Dicker; Alban Linnenbach; Ulrich Rodeck
Journal:  Mol Cancer Ther       Date:  2014-11-14       Impact factor: 6.261

2.  Synthesis of Cyanoenone-Modified Diterpenoid Analogs as Novel Bmi-1-Mediated Antitumor Agents.

Authors:  Lian-Fang Yang; Yajing Xing; Jie-Xin Xiao; Jia Xie; Wei Gao; Jiuqing Xie; Li-Ting Wang; Jinhua Wang; Mingyao Liu; Zhengfang Yi; Wen-Wei Qiu
Journal:  ACS Med Chem Lett       Date:  2018-09-27       Impact factor: 4.345

3.  The role of natural products in revealing NRF2 function.

Authors:  Donna D Zhang; Eli Chapman
Journal:  Nat Prod Rep       Date:  2020-05-13       Impact factor: 13.423

Review 4.  Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease.

Authors:  Karen T Liby; Michael B Sporn
Journal:  Pharmacol Rev       Date:  2012-09-10       Impact factor: 25.468

Review 5.  Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids.

Authors:  Rebecca Borella; Luca Forti; Lara Gibellini; Anna De Gaetano; Sara De Biasi; Milena Nasi; Andrea Cossarizza; Marcello Pinti
Journal:  Molecules       Date:  2019-11-13       Impact factor: 4.411

Review 6.  Preclinical evidences toward the use of triterpenoid CDDO-Me for solid cancer prevention and treatment.

Authors:  Yan-Yang Wang; Hong Zhe; Ren Zhao
Journal:  Mol Cancer       Date:  2014-02-20       Impact factor: 27.401

7.  Ca2+ influx-mediated dilation of the endoplasmic reticulum and c-FLIPL downregulation trigger CDDO-Me-induced apoptosis in breast cancer cells.

Authors:  Soo Ah Jeong; In Young Kim; A Reum Lee; Mi Jin Yoon; Hyeseong Cho; Jong-Soo Lee; Kyeong Sook Choi
Journal:  Oncotarget       Date:  2015-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.